Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects

Figure 1

Mean plasma concentration-time profile of (a) morphine and (b) M6G by treatment (PK population, ).

(a)

(b)